These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS). Chei CL; Yamagishi K; Kitamura A; Kiyama M; Imano H; Ohira T; Cui R; Tanigawa T; Sankai T; Ishikawa Y; Sato S; Iso H Atherosclerosis; 2011 Jul; 217(1):187-93. PubMed ID: 21444086 [TBL] [Abstract][Full Text] [Related]
5. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B; Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420 [TBL] [Abstract][Full Text] [Related]
6. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Di Napoli M; Papa F; Stroke; 2002 Jul; 33(7):1763-71. PubMed ID: 12105349 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke. Kang DW; Yoo SH; Chun S; Kwon KY; Kwon SU; Koh JY; Kim JS Stroke; 2009 May; 40(5):1653-8. PubMed ID: 19265045 [TBL] [Abstract][Full Text] [Related]
8. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Arenillas JF; Alvarez-Sabín J; Molina CA; Chacón P; Montaner J; Rovira A; Ibarra B; Quintana M Stroke; 2003 Oct; 34(10):2463-8. PubMed ID: 14500938 [TBL] [Abstract][Full Text] [Related]
9. Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease. Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW Hypertension; 2005 Jan; 45(1):69-74. PubMed ID: 15569851 [TBL] [Abstract][Full Text] [Related]
10. Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin? O'Donnell MJ; Berge E; Sandset PM Stroke; 2006 Feb; 37(2):452-5. PubMed ID: 16410483 [TBL] [Abstract][Full Text] [Related]
11. Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study. Kaplan RC; McGinn AP; Baird AE; Hendrix SL; Kooperberg C; Lynch J; Rosenbaum DM; Johnson KC; Strickler HD; Wassertheil-Smoller S J Stroke Cerebrovasc Dis; 2008; 17(6):344-55. PubMed ID: 18984425 [TBL] [Abstract][Full Text] [Related]
12. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Barber M; Langhorne P; Rumley A; Lowe GD; Stott DJ Stroke; 2004 Jun; 35(6):1421-5. PubMed ID: 15073383 [TBL] [Abstract][Full Text] [Related]
13. The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan public health center-based study. Iso H; Noda H; Ikeda A; Yamagishi K; Inoue M; Iwasaki M; Tsugane S J Atheroscler Thromb; 2012; 19(8):756-66. PubMed ID: 22785140 [TBL] [Abstract][Full Text] [Related]
14. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245 [TBL] [Abstract][Full Text] [Related]
15. Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study. Folsom AR; Gottesman RF; Appiah D; Shahar E; Mosley TH Stroke; 2016 Jan; 47(1):18-23. PubMed ID: 26556822 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease. Woodward M; Rumley A; Welsh P; MacMahon S; Lowe G J Thromb Haemost; 2007 Sep; 5(9):1795-800. PubMed ID: 17723116 [TBL] [Abstract][Full Text] [Related]
17. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480 [TBL] [Abstract][Full Text] [Related]